We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+2.53%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$46.9M
(-2.3%)
Cap. Flow
-$62.6M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
49.13%
Holding
66
New
15
Increased
17
Reduced
12
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$61.3M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$59.5M |
| 3 |
Universal Health Services
UHS
|
+$53.1M |
| 4 |
AGN
Allergan Inc
AGN
|
+$41.6M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$78.3M |
| 2 |
CFN
CAREFUSION CORPORATION
CFN
|
+$71M |
| 3 |
eHealth
EHTH
|
+$61.7M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.4M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
+$46.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.19% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
eHealth
EHTH
$44.1M
| – | – |
-1,625,000
| Closed | -$61.7M |
|
52
Gilead Sciences
GILD
$161B
| – | – |
-447,600
| Closed | -$37.1M |
|
|
53
PUT
Gilead Sciences
GILD
$161B
| – | – |
-200,000
| Closed | -$16.6M |
|
54
Icon
ICLR
$12.2B
| – | – |
-775,000
| Closed | -$36.5M |
|
55
Jazz Pharmaceuticals
JAZZ
$15.8B
| – | – |
-277,000
| Closed | -$40.7M |
|
56
Merck
MRK
$314B
| – | – |
-611,927
| Closed | -$33.8M |
|
57
Puma Biotechnology
PBYI
$388M
| – | – |
-161,000
| Closed | -$10.6M |
|
58
Teleflex
TFX
$6.26B
| – | – |
-250,000
| Closed | -$26.4M |
|
59
UnitedHealth
UNH
$378B
| – | – |
-41,200
| Closed | -$3.37M |
|
60
Vertex Pharmaceuticals
VRTX
$120B
| – | – |
-250,000
| Closed | -$23.8M |
|
|
AET
61
DELISTED
Aetna Inc
AET
| – | – |
-199,600
| Closed | -$16.2M |
|
|
KYTH
62
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| – | – |
-53,800
| Closed | -$2.06M |
|
|
HSP
63
PUT
DELISTED
HOSPIRA INC
HSP
| – | – |
-600,000
| Closed | -$30.8M |
|
|
CFN
64
DELISTED
CAREFUSION CORPORATION
CFN
| – | – |
-1,600,000
| Closed | -$71M |
|
|
ITMN
65
DELISTED
INTERMUNE INC
ITMN
| – | – |
-237,964
| Closed | -$10.5M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q3 2014 Portfolio in Review
As of Q3 2014, HealthCor Management held 66 positions worth $1.95B, down 2.3% from $1.99B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
HealthCor Management withdrew a net $62.6M in Q3 2014, closing 17 positions and reducing 12 holdings. Its most notable exit was CAREFUSION CORPORATION, an estimated $71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 73% a quarter earlier, followed by Financials.
Against the trend, HealthCor Management opened a new position in Universal Health Services worth $52.3M.
- HealthCor Management's largest Q3 2014 buy was Universal Health Services: 500,000 shares worth $52.3M.
- HealthCor Management added most to Biogen in Q3 2014, an estimated $61.3M increase.
- HealthCor Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $78.3M.
- HealthCor Management fully exited CAREFUSION CORPORATION in Q3 2014, selling an estimated $71M.
- HealthCor Management's ten largest holdings make up 49% of its $1.95B portfolio in Q3 2014.
- HealthCor Management opened 15 new positions and closed 17 in Q3 2014.
- HealthCor Management's portfolio value fell 2.3% quarter-over-quarter to $1.95B.
Based on HealthCor Management's 13F filing for Q3 2014, filed 14 Nov 2014.